Literature DB >> 19377880

Thrombolytic effect of subtilisin QK on carrageenan induced thrombosis model in mice.

Feng Yan1, Junpeng Yan, Weiting Sun, Lunguang Yao, Jiancheng Wang, Yipeng Qi, Hua Xu.   

Abstract

Subtilisin QK, a new fibrinolytic enzyme, could cleave directly cross-linked fibrin in vitro. To verify the thrombolytic function of Subtilisin QK in vivo, the thrombolytic effect of purified Subtilisin QK on tail-thrombus of mouse was investigated. After injected with carrageenan, the tail-thrombus of Subtilisin QK treated group were shorter than the physiological saline treated group. Moreover, the tail-thrombus decreased correlate with Subtilisin QK in a dose-dependent manner. Thrombus nearly disappeared while the mice were treated with 12000 IU Subtilisin QK. The result indicated that Subtilisin QK significantly inhibited thrombus formation in mouse tail. This study made more foundation for further development of Subtilisin QK as a novel bifunctional thrombolytic agent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19377880     DOI: 10.1007/s11239-009-0333-3

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  21 in total

1.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

2.  Subtilisin QK, a fibrinolytic enzyme, inhibits the exogenous nitrite and hydrogen peroxide induced protein nitration, in vitro and in vivo.

Authors:  Juho Ko; Junpeng Yan; Lei Zhu; Yipeng Qi
Journal:  J Biochem Mol Biol       Date:  2005-09-30

3.  The role of platelets in the initial stages of atherosclerosis.

Authors:  L Jørgensen
Journal:  J Thromb Haemost       Date:  2006-07       Impact factor: 5.824

4.  [Development of an animal model of blood stasis syndrome and thrombosis].

Authors:  Ai-hua Liang; Xiao-shuang Ding; Wen Li; Bao-yun Xue; Jin-hua Wang; Hong-jun Yang
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2005-10

5.  Influence of flavonoids and lanthanides on kappa-carrageenin rat tail thrombosis.

Authors:  H Bekemeier; M Gabor; R Hirschelmann
Journal:  Exp Pathol       Date:  1990

6.  Antithrombotic effect of PMC, a potent alpha-tocopherol analogue on platelet plug formation in vivo.

Authors:  G Hsiao; M H Yen; Y M Lee; Joen-Rong Sheu
Journal:  Br J Haematol       Date:  2002-06       Impact factor: 6.998

Review 7.  The functions of plasminogen in cardiovascular disease.

Authors:  Edward F Plow; Jane Hoover-Plow
Journal:  Trends Cardiovasc Med       Date:  2004-07       Impact factor: 6.677

8.  Histological and ultrastructural changes of cardiomyocytes in experimental rats with tail thrombosis following subplantar application of carrageenin.

Authors:  Rostislav Kod'ousek; Jaroslav Jezdínský; Dimitrolos Krajcí
Journal:  Med Princ Pract       Date:  2007       Impact factor: 1.927

Review 9.  Prothrombotic and antithrombotic pathways in acute coronary syndromes.

Authors:  Andrew P Selwyn
Journal:  Am J Cardiol       Date:  2003-06-19       Impact factor: 2.778

10.  Identification of two novel fibrinolytic enzymes from Bacillus subtilis QK02.

Authors:  Ju Ho Ko; Jun Peng Yan; Lei Zhu; Yi Peng Qi
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2004-01       Impact factor: 3.228

View more
  10 in total

1.  Cloning of a fibrinolytic enzyme (subtilisin) gene from Bacillus subtilis in Escherichia coli.

Authors:  Younes Ghasemi; Fatemeh Dabbagh; Abdollah Ghasemian
Journal:  Mol Biotechnol       Date:  2012-09       Impact factor: 2.695

2.  Antithrombotic property of an aqueous extract from Pseudocedrela kotschyi and Adenia cissampeloides.

Authors:  Wilson Bright Nyansah; George Asumeng Koffuor; Inemesit Okon Ben; Linda Gyanfosu; Ben Enoluomen Ehigiator
Journal:  Res Pharm Sci       Date:  2021-06-30

3.  Purification and Characterization of a Fibrinolytic Enzyme from Marine Bacillus velezensis Z01 and Assessment of Its Therapeutic Efficacy In Vivo.

Authors:  Yuting Zhou; Huizhen Chen; Bo Yu; Guiguang Chen; Zhiqun Liang
Journal:  Microorganisms       Date:  2022-04-20

4.  Preventive Effect of Aspirin Eugenol Ester on Thrombosis in κ-Carrageenan-Induced Rat Tail Thrombosis Model.

Authors:  Ning Ma; Xi-Wang Liu; Ya-Jun Yang; Jian-Yong Li; Isam Mohamed; Guang-Rong Liu; Ji-Yu Zhang
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

5.  Subtilisin QK-2: secretory expression in Lactococcus lactis and surface display onto gram-positive enhancer matrix (GEM) particles.

Authors:  Ruifeng Mao; Kangping Zhou; Zhenwei Han; Yefu Wang
Journal:  Microb Cell Fact       Date:  2016-05-12       Impact factor: 5.328

6.  Exploring the Fibrin(ogen)olytic, Anticoagulant, and Antithrombotic Activities of Natural Cysteine Protease (Ficin) with the κ-Carrageenan-Induced Rat Tail Thrombosis Model.

Authors:  Hye Ryeon Yang; Du Hyeon Hwang; Ramachandran Loganathan Mohan Prakash; Jong-Hyun Kim; Il-Hwa Hong; Suk Kim; Euikyung Kim; Changkeun Kang
Journal:  Nutrients       Date:  2022-08-29       Impact factor: 6.706

7.  Thrombolytic effects of Douchi fibrinolytic enzyme from Bacillus subtilis LD-8547 in vitro and in vivo.

Authors:  Jun Yuan; Jing Yang; Zhenhong Zhuang; Yanling Yang; Ling Lin; Shihua Wang
Journal:  BMC Biotechnol       Date:  2012-07-02       Impact factor: 2.563

8.  Medium optimization for the production of fibrinolytic enzyme by Paenibacillus sp. IND8 using response surface methodology.

Authors:  Ponnuswamy Vijayaraghavan; Samuel Gnana Prakash Vincent
Journal:  ScientificWorldJournal       Date:  2014-01-09

9.  Evaluation on antithrombotic effect of aspirin eugenol ester from the view of platelet aggregation, hemorheology, TXB2/6-keto-PGF1α and blood biochemistry in rat model.

Authors:  Ning Ma; Xi-Wang Liu; Ya-Jun Yang; Dong-Shuai Shen; Xiao-Le Zhao; Isam Mohamed; Xiao-Jun Kong; Jian-Yong Li
Journal:  BMC Vet Res       Date:  2016-06-14       Impact factor: 2.741

10.  Safety assessment of subtilisin QK in rats.

Authors:  Shuai Xiao; Dingbang Hu; Ya Gao; Yang Ai; Sang Luo; Song Chen; Ben Wang; Li Zhou; Yanshan Dong; Yefu Wang
Journal:  BMC Pharmacol Toxicol       Date:  2021-06-26       Impact factor: 2.483

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.